Shares Outstanding for Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's latest reported diluted shares outstanding is 157.00M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
TECH
Currently viewingShares OutstandingSwitch metric
Latest period
157.00M
YoY change
-0.7%
5Y CAGR
+0.3%
Peak year (2001)
170.67M
Latest annual
159.72M
Shares Outstanding history chart for Bio-Techne (TECH) from 1989 to 2025
Shares Outstanding history table for Bio-Techne (TECH) from 1989 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 159.72M | -0.7% | ||
| 2024 | 160.77M | -0.7% | ||
| 2023 | 161.85M | -1.4% | ||
| 2022 | 164.12M | +1.3% | ||
| 2021 | 161.93M | +2.7% | ||
| 2020 | 157.60M | +1.3% | ||
| 2019 | 155.57M | +2.2% | ||
| 2018 | 152.22M | +1.5% | ||
| 2017 | 150.00M | +0.5% | ||
| 2016 | 149.30M | +0.3% | ||
| 2015 | 148.92M | +0.6% | ||
| 2014 | 148.02M | +0.3% | ||
| 2013 | 147.60M | -0.3% | ||
| 2012 | 148.02M | -0.4% | ||
| 2011 | 148.69M | -0.5% | ||
| 2010 | 149.39M | -1.5% | ||
| 2009 | 151.60M | -3.4% | ||
| 2008 | 156.99M | -0.7% | ||
| 2007 | 158.05M | -0.2% | ||
| 2006 | 158.38M | -3.2% | ||
| 2005 | 163.68M | -1.9% | ||
| 2004 | 166.79M | -0.8% | ||
| 2003 | 168.12M | -1.2% | ||
| 2002 | 170.09M | -0.3% | ||
| 2001 | 170.67M | +1.1% | ||
| 2000 | 168.82M | +2.0% | ||
| 1999 | 165.49M | +5.5% | ||
| 1998 | 156.86M | +0.7% | ||
| 1997 | 155.71M | +0.1% | ||
| 1996 | 155.54M | +1.4% | ||
| 1995 | 153.33M | +5.2% | ||
| 1994 | 145.71M | -0.6% | ||
| 1993 | 146.67M | +10.0% | ||
| 1992 | 133.33M | +4.2% | ||
| 1991 | 128.00M | -4.0% | ||
| 1990 | 133.33M | +5.7% | ||
| 1989 | 126.14M | — |
Shares Outstanding values are taken from Bio-Techne's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Bio-Techne (TECH) reported diluted shares outstanding of 159.72M – edged down 0.7% year-over-year.
Bio-Techne diluted shares outstanding compound annual growth for the 2020–2025 (5 years) window is +0.3%, with the latest reading among the more recent periods of the dataset.
Between 2001 and 2025, Bio-Techne diluted shares outstanding declined 6.4%, falling from 170.67M to 159.72M.
The dataset's maximum diluted shares outstanding sits at 170.67M (2001); the minimum reading of 126.14M dates to 1989.
Within Healthcare, Bio-Techne (TECH) ranks 9th among 8 peers we track. The peer median for diluted shares outstanding is 1.34B.
Bio-Techne Shares Outstanding by Year
Bio-Techne Shares Outstanding 2025: 159.72M
Bio-Techne diluted shares outstanding in 2025 was 159.72M, edged down 0.7% below 2024.
Bio-Techne Shares Outstanding 2024: 160.77M
Bio-Techne diluted shares outstanding in 2024 was 160.77M, edged down 0.7% below 2023.
Bio-Techne Shares Outstanding 2023: 161.85M
Bio-Techne diluted shares outstanding in 2023 was 161.85M, edged down 1.4% below 2022.
Bio-Techne Shares Outstanding 2022: 164.12M
Bio-Techne diluted shares outstanding in 2022 was 164.12M, edged up 1.3% from 2021.
Bio-Techne Shares Outstanding 2021: 161.93M
Bio-Techne diluted shares outstanding in 2021 was 161.93M.
See more financial history for Bio-Techne (TECH).
Sector peers — Shares Outstanding
Companies in the same sector as Bio-Techne, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is Bio-Techne's diluted shares outstanding?
- Latest reported diluted shares outstanding for Bio-Techne (TECH) is 157.00M (period ending December 31, 2025).
How has Bio-Techne diluted shares outstanding changed year-over-year?
- Bio-Techne (TECH) diluted shares outstanding changed -0.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Bio-Techne diluted shares outstanding?
- Bio-Techne (TECH) diluted shares outstanding compound annual growth rate is +0.3% over the most recent 5 years available.
When did Bio-Techne diluted shares outstanding hit its highest annual value?
- Bio-Techne diluted shares outstanding reached its highest annual value of 170.67M in 2001.
What was Bio-Techne diluted shares outstanding in 2024?
- Bio-Techne (TECH) diluted shares outstanding in 2024 was 160.77M.
What was Bio-Techne diluted shares outstanding in 2025?
- Bio-Techne (TECH) diluted shares outstanding in 2025 was 159.72M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TECH Overview
Company profile, financial tools, and key metrics
TECH Revenue Counter
Earns $38.55 every second. See per minute, hour, and day.
TECH Earnings Counter
Earns $2.57 per second net profit. See per minute, hour, and day.
TECH Economic Scale
Exceeds Samoa's GDP. Compare with world economies.
TECH What If Invested
What if you had invested $1,000? See historical returns from any date.
TECH How It Makes Money
Discover visual breakdown of $1.22B in revenue — where it comes from and where it goes.
TECH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TECH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TECH Daily Price Character
Balanced · 45.3% historical win rate (green days). Streaks & record days.
TECH Buybacks
2.18% TTM buyback yield. Shareholder yield & SBC comparison.
TECH Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
TECH Dividend Profile
Yield: 0.62%. Safety: 5/8. See full history.
TECH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TECH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.